← Open Payments lookup

JESSICA BELL: Open Payments

NPI 1700409711 · HARRISBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,904 in 227 payments from 21 companies in 2025. Trend: 2023 $2,278 · 2024 $2,892 · 2025 $3,904

Food & beverage: $3,820Education: $84
CompanyPaymentsAmount
ABBVIE INC.45$912
Janssen Biotech, Inc.49$772
Madrigal Pharmaceuticals14$490
Salix Pharmaceuticals, a division of Bausch Health US, LLC25$275
Takeda Pharmaceuticals U.S.A., Inc.18$222
Regeneron Healthcare Solutions, Inc.14$214
Novo Nordisk Inc7$197
Celltrion USA Inc.13$195
Ipsen Biopharmaceuticals, Inc7$110
Lilly USA, LLC5$103

Products named: TREMFYA, REZDIFFRA, RINVOQ, DUPIXENT, XIFAXAN, LINZESS, Wegovy, VEGZELMA.

Industry payments across PA — which companies pay providers there.